Sinopharm COVID-19 vaccine, developed by Sinopharm/China National Pharmaceutical Group

FDA Needs Info on Sinopharm Vaccine Use in Children

BANGKOK, Sept 21 (TNA) – The Food and Drug Administration has not approved the administration of the COVID-19 vaccine made by Sinopharm for children aged 3 and over on insufficient safety information and urged Biogenetech Co to give more information.

FDA secretary-general Dr. Paisarn Dunkum said Biogenetech which was the approved importer of the Sinopharm vaccine sought permission from the FDA to lower the minimum age of recipients of the Sinopharm vaccine from 18 to 3 years old.

Full story:



The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply